Kinetic Study of Lp(a) and PCSK9 in Humans

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

July 31, 2020

Primary Completion Date

December 23, 2021

Study Completion Date

December 23, 2021

Conditions
Cholesterol; Metabolic DisorderLipoproteinemia
Interventions
OTHER

infusion of tracer [5,5,5-2H3] -L-leucine

A bolus of 6ml of \[5,5,5-2H3\] -L-leucine tracers will be performed followed by an infusion of 90 ml of \[5,5,5-2H3\] -L-leucine infused over 14 hours. This tracer participates in protein synthesis and especially in the synthesis of all apolipoproteins and PCSK9. Blood samples will be taken at T0, T2min, T5min, T10 minutes, T30 minutes and then every hour until 14 hours (a total of 240 ml of blood will be collected) to measure the stable tracer enrichment in the proteins of interest.

Trial Locations (1)

44093

Nantes University Hospital, Nantes

All Listed Sponsors
collaborator

Centre de Recherche en Nutrition Humaine Ouest (CRNH)

UNKNOWN

lead

Nantes University Hospital

OTHER

NCT04247048 - Kinetic Study of Lp(a) and PCSK9 in Humans | Biotech Hunter | Biotech Hunter